All of Us Research Program Expands Data Collection Efforts with Fitbit NIH, January 16, 2018

Main|Search|PHGKB




Last Posted: Jan 18, 2019

---

• All of Us Research Program Expands Data Collection Efforts with Fitbit
  NIH, January 16, 2018
• [Clinical Applications of Next-Generation Sequencing].
  Rebollar-Vega Rosa Gloria et al. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 2018 70(4) 153-157
• Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.
  Winter Max-Paul et al. European heart journal. Cardiovascular pharmacotherapy 2017 3(4) 221-234
• Improving genetic prediction by leveraging genetic correlations among human diseases and traits.
  Maier Robert M et al. Nature communications 2018 9(1) 989
• Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
  Bankhead Peter et al. Laboratory investigation; a journal of technical methods and pathology 2018 98(1) 15-26
• Is Careful Assessment of Rare Variants in the RYR2 Gene Piercing the Guidelines' Strong Armor?
  Schwartz Peter J et al. Circulation. Genomic and precision medicine 2018 11(2) e002072
• Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.
  Stoeklé Henri-Corto et al. Science and engineering ethics 2018 24(1) 307-322
• Road to Unravel Gene-Environment Interactions on Cardiovascular Complex Diseases.
  Elosua Roberto et al. Circulation. Genomic and precision medicine 2018 11(1) e002040
• 23andMe is offering pharmacogenetic testing, but is it any good?
  Precision Medicine Advisors, January 16, 2019
• Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
  Giraldo Nicolas A et al. Virchows Archiv : an international journal of pathology 2019 Jan

more